Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGoodwin Regulatory News (GDWN)

Share Price Information for Goodwin (GDWN)

Share Price is delayed by 15 minutes
Get Live Data
17,160.00    60.00 (0.35%)
Bid:
17,020.00
Ask:
17,080.00
Spread: 60.00 (0.353%)
Market Cap: £1.31b
GDWN Live PriceLast checked at - London Stock Exchange

Intraday Goodwin Share Chart

March 2025 Trading Update

19 Mar 2025 08:00

RNS Number : 2754B
Goodwin PLC
19 March 2025
 

GOODWIN PLC

MARCH 2025 TRADING UPDATE

 

We are pleased to report that as of the end of February, the Group's forward order book has reached a new record of £300 million. This milestone reflects the strength of our long-term established contracts and the robustness of our business activities. As a result, we remain on track to deliver second-half profits comparable to those of the first half of the year.

 

One of the recent contributors to this success has been Noreva, our specialised nozzle check valve company based in Germany. Noreva has secured the largest order in its history-a $15 million contract to supply valves for an LNG project. This contract, to be fulfilled over the next two years, positions us well to benefit from the expected release of further LNG projects, in light of the growing global demand for LNG. 

 

The vertical integration within our Group continues to provide a substantial competitive advantage. A significant proportion of the castings for Noreva's major order will be sourced from Goodwin Steel Castings (GSC), our own foundry. Even though we are now casting at a rate of 10 Self Shielded Boxes (SSBs) per month for the nuclear decommissioning market, as well as continuing to cast components for the military contracts that GSC has won, all with multi-year delivery profiles and high likelihood of repeat orders, the foundry still has capacity to take on additional contracts. This puts us in an excellent position to continue to contribute to national strategic defence procurements in both the UK and USA.

 

Looking ahead, the Mechanical Division is poised for further success. While the majority of orders received this year will start to deliver financial returns in the next fiscal year, we are confident that this momentum will continue to build. Our significant investment over the past decade has equipped the Mechanical Division with the necessary facilities, size, and capability to handle increasing workloads across all areas. Our investment into the Goodwin Engineering Training Centre has also supported this growth by successfully operating for over 13 years and training over 300 apprentices to date. It is these individuals who now form part of the Group's highly skilled workforce that is required to sustain our expansion.

 

Meanwhile, our Refractory Division continues to grow and perform well. The investment casting markets, particularly in the jewellery sectors are expanding at an impressive rate, exceeding 10% growth in certain regions. As a global market leader, we are benefiting directly from this trend, with our powder companies in China, India and Thailand achieving record in-month results compared to previous years.

 

Capital expenditure across the Group has decreased significantly as expected. The primary ongoing project, which is non customer funded, is the construction of a new 1,200 m² building at Noreva. Over the next few months, once the equipment has been delivered and installed, this facility will house a CNC press operation converting Duvelco polyimide resin powder into precision pressed parts. With the reduced capital expenditure and our improved profitability, we have successfully reduced Group net debt by a further £10 million since the half-year mark.

 

Finally, with respect to dividend payments, we re-confirm that the second and final instalment of 66.5p per share for the year ending 30th April 2024, approved at our last Annual General Meeting on 2nd October 2024, will be paid on 11th April 2025 to shareholders registered on 21st March 2025.

 

The Board is delighted with the Group's performance and the strategic positioning we have achieved. With our record order book, expanding capabilities, and strong financial foundation, we are well-placed to sustain our success and drive further growth in profitability.

 

T.J.W. Goodwin

Chairman

 

END LEI: 213800N4T1NMSJ57B322

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGRGDXLXBDGUC
Date   Source Headline
23rd Dec 20084:34 pmRNSDirector/PDMR Shareholding
17th Dec 20085:14 pmRNSHalf Yearly Report
29th Sep 20081:50 pmRNSDirectorate Change
23rd Sep 200810:42 amRNSDirector/PDMR Shareholding
9th Sep 20082:00 pmRNSInterim Management Statement
1st Sep 200812:16 pmRNSDoc re.Report and Accounts
22nd Aug 20084:33 pmRNSFinal Results
30th Jun 20082:32 pmRNSAcquisition of SRS Holdings L
7th Apr 20086:22 pmRNSDirector/PDMR Shareholding
12th Mar 200810:24 amRNSRe Contract
7th Mar 20082:00 pmRNSInterim Management Statement
15th Jan 20085:14 pmRNSDirector/PDMR Shareholding
21st Dec 20075:10 pmRNSDoc re. Interim Accounts
21st Dec 20074:46 pmRNSDirector/PDMR Shareholding
21st Dec 20079:00 amRNSInterim Results
16th Oct 20075:49 pmRNSDirector/PDMR Shareholding
10th Oct 20074:22 pmRNSAnnual Information Update
24th Sep 200710:16 amRNSDoc re. Report and Accounts
14th Sep 20073:00 pmRNSInterim Management Statement
24th Aug 20073:01 pmRNSFinal Results
23rd Mar 20079:15 amRNSAcquisition
30th Jan 20079:45 amRNSDoc re.Unaudited Interim Acct
29th Jan 20075:44 pmRNSDirector/PDMR Shareholding
26th Jan 20079:00 amRNSInterim Results
22nd Dec 20069:14 amRNSAppointment of Directors
8th Dec 200612:13 pmRNSTotal Voting Rights
17th Nov 20063:51 pmRNSDirector/PDMR Shareholding
9th Oct 20066:03 pmRNSAnnual Information Update
25th Sep 20069:09 amRNSDoc re. Report and Accounts
25th Aug 20063:00 pmRNSFinal Results
22nd Jun 20065:50 pmRNSDirector/PDMR Shareholding
26th May 20063:37 pmRNSDirector/PDMR Shareholding
24th Mar 20063:09 pmRNSDirector/PDMR Shareholding
20th Mar 200611:29 amRNSDirectorate Change
30th Jan 20069:40 amRNSDoc re. Interim Accounts
27th Jan 20063:00 pmRNSInterim Results
22nd Nov 20054:37 pmRNSDirector/PDMR Shareholding
10th Nov 200512:36 pmRNSAnnual Information Update
26th Sep 20059:59 amRNSDoc re Report and Accounts
9th Sep 20052:17 pmRNSDirector/PDMR Shareholding
26th Aug 20053:00 pmRNSFinal Results
10th May 20053:26 pmRNSDirector Shareholding
11th Apr 20054:37 pmRNSHolding(s) in Company
7th Apr 200512:39 pmRNSDirector Shareholding
5th Apr 200511:34 amRNSDirector Shareholding-Amend
4th Apr 20055:00 pmRNSDirector Shareholding
31st Mar 20053:06 pmRNSDirector Shareholding
31st Jan 200512:37 pmRNSDoc re Unaudited Interim Acct
28th Jan 20053:00 pmRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.